Clinical Trial Update: Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial updating efficacy and safety of ambrisentan in Chinese patients with pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

Sponsor: RenJi Hospital | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED